Following studies showing that cancer cases in India may rise to up to 78 per cent by 2030, oncology is all set to receive focus in Biopharmaceutical research, said experts.
At a seminar on Biotechnology and Bio Pharmaceuticals at the recently concluded GIM-2102, managing director of Evolva Biotech P M Murali said that in the future oncology will fuel research in India.
“We have the largest number of head and neck cancer cases. The pharmaceutical industry will have to attend to this growing number and so research in the sector will rise,” he said. Murali added affordability will be the mantra for research in India.
Kiran Mazumdar Shaw of Biocon said, The field of oncology research is extremely important. There are some key areas like diagnostics that are of crucial importance.” Murali also added that the Central government was making efforts to frame policies which would make India the hub of biomanufacturing.